Kevan C. Herold

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold, Brian N. Bundy, S. Alice Long et al. · New England Journal of Medicine · 2019 · 1K citations · Full text

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. Bluestone, Jane H. Buckner, Mark Fitch et al. · Science Translational Medicine · 2015 · 993 citations

Translational Medicine, Diabetes Management, Autoimmune Disease +13

Reprogramming human T cell function and specificity with non-viral genome targeting

Theodore L. Roth, Cristina Puig-Saus, Ruby Yu et al. · Nature · 2018 · 817 citations · Full text

Immunological Memory, Non-viral Genome Targeting, Adaptive Immune System +9

Control of TH17 cells occurs in the small intestine

Enric Esplugues, Samuel Huber, Nicola Gagliani et al. · Nature · 2011 · 643 citations

Mucosal Immunology, Small Intestine, Immunology +8